In the Journals

Cryolipolysis offers significant reduction of lateral thigh fat

Researchers reported recently that the cryolipolysis conformable-surface applicator was effective for the treatment of lateral thigh fat with no serious adverse events.

In a prospective, interventional cohort, multicenter study, the researchers performed a 120-minute unilateral treatment with a prototype conformable-surface applicator on one lateral thigh of 40 patients. Patients’ untreated thighs served as the controls. Follow-up visits took place at 2 and 4 months and involved ultrasound imaging and clinical photography, as well as the completion of patient satisfaction surveys.

Through ultrasound results, the researchers found a 2.6-mm mean reduction in fat thickness, which was statistically significant compared with the untreated thigh.

Patient survey responses demonstrated that 89% of patients would recommend the procedure to a friend. Eighty-six percent of the patients reported satisfaction with the results of cryolipolysis for the lateral thigh area, and 86% reported a visible reduction in fat. Ninety-seven percent of the patients also reported they would be likely to undergo a second treatment, according to the researchers.

Three independent blinded physicians were able to correctly identify patients’ baseline and post-treatment photos in 87% of the cases observed.

No serious adverse events or unexpected device-related adverse effects occurred, according to the researchers. – by Abigail Sutton

Disclosure: Stevens is an investigator for Sientra & Silimed, Cohera Medical and Mentor CPG; medical luminary for BTL, Merz and Syneron-Candela; speaker for Allergan Academy and Cynosure; consultant for TauTona; medical luminary and speaker for Cutera and Solta; and medical luminary, investigator and speaker for Zeltiq. Please see the full study for a list of all other authors’ relevant financial disclosures.

Researchers reported recently that the cryolipolysis conformable-surface applicator was effective for the treatment of lateral thigh fat with no serious adverse events.

In a prospective, interventional cohort, multicenter study, the researchers performed a 120-minute unilateral treatment with a prototype conformable-surface applicator on one lateral thigh of 40 patients. Patients’ untreated thighs served as the controls. Follow-up visits took place at 2 and 4 months and involved ultrasound imaging and clinical photography, as well as the completion of patient satisfaction surveys.

Through ultrasound results, the researchers found a 2.6-mm mean reduction in fat thickness, which was statistically significant compared with the untreated thigh.

Patient survey responses demonstrated that 89% of patients would recommend the procedure to a friend. Eighty-six percent of the patients reported satisfaction with the results of cryolipolysis for the lateral thigh area, and 86% reported a visible reduction in fat. Ninety-seven percent of the patients also reported they would be likely to undergo a second treatment, according to the researchers.

Three independent blinded physicians were able to correctly identify patients’ baseline and post-treatment photos in 87% of the cases observed.

No serious adverse events or unexpected device-related adverse effects occurred, according to the researchers. – by Abigail Sutton

Disclosure: Stevens is an investigator for Sientra & Silimed, Cohera Medical and Mentor CPG; medical luminary for BTL, Merz and Syneron-Candela; speaker for Allergan Academy and Cynosure; consultant for TauTona; medical luminary and speaker for Cutera and Solta; and medical luminary, investigator and speaker for Zeltiq. Please see the full study for a list of all other authors’ relevant financial disclosures.